Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings

Background: A see on cardiovascular diseases and bladder cancer. The changes to the patterns of rosiglitazone and pioglitazone utilisation in Australia following the timing of these various health authority warnings such as the Australian Therapeutic Good Administration (TGA), European Medicines Age...

Full description

Saved in:
Bibliographic Details
Main Authors: Suvimol Niyomnaitham, Andrew Page, Adam La Caze, Karen Whitfield, Alesha J. Smith
Other Authors: University of Queensland
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/34255
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
Be the first to leave a comment!
You must be logged in first